SEC Form 4 · accession 0001209191-15-086218
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank H Valone M.D.
Officer — Chief Medical Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 18, 2015 · 8:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2015 | G | 2,500 | $0.00 | D | 86,840 | D | |
| Common Stock | holding | — | — | — | 4,000 | I | By trust |
Table II — derivative securities
No Table II lines on this filing.